搜尋
60 Degrees Pharmaceuticals Inc
SXTP添加自選
1.710USD
-0.040-2.29%
收盤 07/02, 13:00（美東）報價延遲15分鐘
1.75M總市值
虧損本益比TTM
關於 60 Degrees Pharmaceuticals Inc 公司
60 Degrees Pharmaceuticals, Inc. is a specialty pharmaceutical company. The Company specializes in developing and marketing new medicines for the treatment and prevention of infectious diseases. It is focused on using biological science and applied research to develop and commercialize new therapies for the prevention and treatment of infectious diseases. The Company's pipeline under development covers development programs for vector-borne, fungal, and viral disease utilizing three of the Company’s products: new products that contain the ARAKODA regimen of Tafenoquine; new products that contain Tafenoquine, and Celgosivir. Its lead product, ARAKODA is used for malaria prevention in individuals 18 years and older. It is also conducting due diligence activities in relation to potential in-licensing of a product relevant to Lyme disease and an antimalarial combination partner for Tafenoquine for P. vivax malaria.
60 Degrees Pharmaceuticals Inc簡介
公司代碼SXTP
公司名稱60 Degrees Pharmaceuticals Inc
上市日期Jul 12, 2023
CEODow (Geoffrey S)
員工數量3
證券類型Ordinary Share
年結日Jul 12
公司地址1025 Connecticut Avenue Nw
城市WASHINGTON
上市交易所NASDAQ OMX - NASDAQ BASIC
國家United States of America
郵編20036
電話12023275422
網址https://60degreespharma.com/
公司代碼SXTP
上市日期Jul 12, 2023
CEODow (Geoffrey S)
60 Degrees Pharmaceuticals Inc公司高管
名稱
名稱/職務
職務
持股
持股變動
Dr. Geoffrey S. Dow, Ph.D.
Dr. Geoffrey S. Dow, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
24.13K
+30.46%
Ms. Cheryl Xu
Ms. Cheryl Xu
Director
Director
3.95K
--
Mr. Tyrone Miller
Mr. Tyrone Miller
Chief Financial Officer
Chief Financial Officer
1.32K
--
Ms. Kristen Landon
Ms. Kristen Landon
Chief Commercial Officer
Chief Commercial Officer
1.14K
--
Mr. Charles W. Allen
Mr. Charles W. Allen
Independent Director
Independent Director
59.00
--
Dr. Stephen Toovey
Dr. Stephen Toovey
Independent Director
Independent Director
59.00
--
Mr. Paul Field
Mr. Paul Field
Independent Director
Independent Director
59.00
--
Mr. Patrick Gaynes
Mr. Patrick Gaynes
Investor Relations Officer
Investor Relations Officer
--
--
名稱
名稱/職務
職務
持股
持股變動
Dr. Geoffrey S. Dow, Ph.D.
Dr. Geoffrey S. Dow, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
24.13K
+30.46%
Ms. Cheryl Xu
Ms. Cheryl Xu
Director
Director
3.95K
--
Mr. Tyrone Miller
Mr. Tyrone Miller
Chief Financial Officer
Chief Financial Officer
1.32K
--
Ms. Kristen Landon
Ms. Kristen Landon
Chief Commercial Officer
Chief Commercial Officer
1.14K
--
Mr. Charles W. Allen
Mr. Charles W. Allen
Independent Director
Independent Director
59.00
--
Dr. Stephen Toovey
Dr. Stephen Toovey
Independent Director
Independent Director
59.00
--
常見問題
60 Degrees Pharmaceuticals Inc的前五大股東是誰？
60 Degrees Pharmaceuticals Inc的前五大股東如下：Dr. Geoffrey S. Dow, Ph.D.
有多少機構持有60 Degrees Pharmaceuticals Inc(SXTP)的股份？
截至2026Q1，共有27家機構持有60 Degrees Pharmaceuticals Inc的股份，合計持有的股份價值約為228.38K，占公司總股份的8.66% 。與2025Q4相比，機構持股有所增加，增幅為141573.00。